Ignite Creation Date:
2024-05-05 @ 11:49 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00144144
Status:
UNKNOWN
Last Update Posted:
2006-07-14
First Post:
2005-09-01
Brief Title:
A Study on Ca Blocker Versus AII Antagonists in Hypertension With Type 2 Diabetes
Sponsor:
Advanced-J
Organization:
Advanced-J
Study Overview
Official Title:
A Randomized Controlled Study on Calcium Channel Blocker Versus Angiotensin II Antagonists in the Hypertensive Patients With Type 2 Diabetes Mellitus Under the Inadequately Controlled Blood Pressure With Angiotension II Antagonists
Status:
UNKNOWN
Status Verified Date:
2006-07
Last Known Status:
ACTIVE_NOT_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The antihypertensive effect of the increased dose of angiotensin II receptor blocker AII antagonist is compared with that of the additional combined use of amlodipine in hypertensive patients with Type 2 diabetes mellitus who have been treated with AII antagonist the antihypertensive effect of which has been inadequate
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| UMIN-C000000017 | None | None | None |